Nicotine Patch + Counseling for Smoking Cessation

Not yet recruiting at 4 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

Who Is on the Research Team?

MP

Megan Piper, PhD

Principal Investigator

UW School of Medicine and Public Health

Are You a Good Fit for This Trial?

Inclusion Criteria

* self-identify as Black
* smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
* motivated to quit smoking
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive one of three interventions: Standard, Intensive, or Intensive Incentivized, involving nicotine patches and counseling sessions

8 weeks
8 counseling sessions (phone or virtual)

Follow-up

Participants are monitored for smoking cessation and other outcomes post-treatment

26 weeks
Assessments at 8 and 26 weeks post-TQD

What Are the Treatments Tested in This Trial?

Interventions

  • Nicotine patch

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Active Control

Group I: Intensive InterventionExperimental Treatment3 Interventions
Group II: Intensive Incentivized InterventionExperimental Treatment4 Interventions
Group III: Standard InterventionActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+